RCUS Operating Expenses

Arcus Biosciences Inc · Operating Expenses

RCUS logo

RCUS Operating Expenses

Latest reported$596.00M
RCUS TTM Operating Expenses ($54.86M → $596.00M)
High-resolution chart · PNG

RCUS operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arcus Biosciences Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
596,000,000
627,000,000
628,000,000
613,000,000
600,000,000
577,000,000
588,000,000
581,000,000
540,000,000
507,000,000
457,000,000
443,096,000
434,096,000
418,096,000
392,096,000
357,232,000
341,829,000
331,426,000
328,634,000
316,901,000
292,282,000
253,810,000
201,752,000
167,530,000
129,551,000
113,336,000
103,709,000
91,478,000
82,915,000
69,154,000
63,212,000
62,760,000
69,621,000
62,136,000
54,855,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.